Chinese Sho-saiko-to "helped to prevent" hepatocellular carcinomas -- Cancer study.
This article was originally published in The Tan Sheet
Executive Summary
CHINESE SHO-SAIKO-TO "HELPED TO PREVENT" LIVER CANCER, researchers from Osaka City University Medical School, Osaka City General Hospital, Sumiyoshi Municipal Hospital, Kobe Asahi Hospital and the Institute of Public Health in Tokyo report in the Sept. 1 issue of Cancer. Hiroko Oka et al. concluded that the Chinese herbal remedy Sho-saiko-to (TJ-9) "helped to prevent the development of hepatocellular carcinomas in patients with cirrhosis, particularly in patients without [hepatitis B] antigen." Hepatocellular carcinoma (HCC) is a common cancer, often found in patients with underlying cirrhosis.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning